1. Home
  2. LIXT vs AIRI Comparison

LIXT vs AIRI Comparison

Compare LIXT & AIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIXT
  • AIRI
  • Stock Information
  • Founded
  • LIXT 2005
  • AIRI 1979
  • Country
  • LIXT United States
  • AIRI United States
  • Employees
  • LIXT N/A
  • AIRI N/A
  • Industry
  • LIXT Biotechnology: Pharmaceutical Preparations
  • AIRI Military/Government/Technical
  • Sector
  • LIXT Health Care
  • AIRI Industrials
  • Exchange
  • LIXT Nasdaq
  • AIRI Nasdaq
  • Market Cap
  • LIXT 12.4M
  • AIRI 13.4M
  • IPO Year
  • LIXT N/A
  • AIRI N/A
  • Fundamental
  • Price
  • LIXT $4.85
  • AIRI $3.38
  • Analyst Decision
  • LIXT
  • AIRI
  • Analyst Count
  • LIXT 0
  • AIRI 0
  • Target Price
  • LIXT N/A
  • AIRI N/A
  • AVG Volume (30 Days)
  • LIXT 193.9K
  • AIRI 86.6K
  • Earning Date
  • LIXT 08-07-2025
  • AIRI 08-18-2025
  • Dividend Yield
  • LIXT N/A
  • AIRI N/A
  • EPS Growth
  • LIXT N/A
  • AIRI N/A
  • EPS
  • LIXT N/A
  • AIRI N/A
  • Revenue
  • LIXT N/A
  • AIRI $53,182,000.00
  • Revenue This Year
  • LIXT N/A
  • AIRI N/A
  • Revenue Next Year
  • LIXT N/A
  • AIRI $4.99
  • P/E Ratio
  • LIXT N/A
  • AIRI N/A
  • Revenue Growth
  • LIXT N/A
  • AIRI 0.29
  • 52 Week Low
  • LIXT $0.64
  • AIRI $3.00
  • 52 Week High
  • LIXT $5.14
  • AIRI $9.44
  • Technical
  • Relative Strength Index (RSI)
  • LIXT 64.92
  • AIRI 46.97
  • Support Level
  • LIXT $4.20
  • AIRI $3.30
  • Resistance Level
  • LIXT $5.06
  • AIRI $3.45
  • Average True Range (ATR)
  • LIXT 0.44
  • AIRI 0.09
  • MACD
  • LIXT -0.02
  • AIRI -0.01
  • Stochastic Oscillator
  • LIXT 80.79
  • AIRI 32.00

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About AIRI Air Industries Group

Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.

Share on Social Networks: